Pre-exposure prophylaxis implementation during incarceration: Perspectives of formerly incarcerated men and women

被引:0
|
作者
Banyas, Elizabeth Anna [1 ]
Castleman, Madelaine F. [1 ]
Rahim, Husnah A. [1 ]
Okumu, Eunice [2 ]
White, Becky L. [3 ]
机构
[1] Univ North Carolina, Chapel Hill, NC 27515 USA
[2] Univ North Carolina, UNC Ctr AIDS Res, Chapel Hill, NC 27515 USA
[3] Univ North Carolina, Dept Med, Chapel Hill, NC 27515 USA
来源
PLOS ONE | 2024年 / 19卷 / 12期
关键词
HIV; TRANSMISSION; LINKAGE; PRISON; RISK;
D O I
10.1371/journal.pone.0311289
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The HIV prevalence is higher among individuals involved in the United States (U.S.) correctional system than those in general population. Despite this, people in prisons or other closed settings have poor access to the most effective biomedical prevention tool, HIV pre-exposure prophylaxis (PrEP). The purpose of this study was to explore the attitudes and beliefs of PrEP initiation in correctional facilities amongst individuals formerly in prisons or other closed settings. We conducted 13 in-depth qualitative interviews with recently released (from incarceration) clients participating in a formerly incarcerated transition program in the southern United States. We identified several themes from our interviews. These themes were 1) PrEP information during incarceration; 2) Risky behaviors during incarceration and post-release; 3) Anticipated post-release challenges to accessing PrEP. Individuals formerly in prisons or other closed settings desire more education about PrEP during incarceration. They also want to learn more about HIV prevention measures. They believe that initiating PrEP in prison would allow a seamless transition to post-release PrEP programs. In conclusion, initiating PrEP during incarceration is one strategy to increase access to PrEP among the medically underserved criminal-justice population.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Implementation models and access to HIV pre-exposure prophylaxis in Spain
    Mir, Joan Francesc
    Mazario, Manuel F.
    Coll, Pep
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2020, 38 (05): : 234 - 237
  • [32] Pre-exposure Prophylaxis Persistence Is a Critical Issue in PrEP Implementation
    Spinelli, Matthew A.
    Buchbinder, Susan P.
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (03) : 583 - 585
  • [33] IMPLEMENTATION OF AN HIV PRE-EXPOSURE PROPHYLAXIS STRATEGY INTO ABORTION CARE
    Sonalkar, S.
    Fishman, J.
    Kete, C.
    McAllister, A.
    Frarey, A.
    Short, W. R.
    Schreiber, C. A.
    Teitelman, A.
    CONTRACEPTION, 2021, 104 (04) : 450 - 450
  • [34] Implementation science of pre-exposure prophylaxis: Preparing for public Use
    Underhill K.
    Operario D.
    Mimiaga M.J.
    Skeer M.R.
    Mayer K.H.
    Current HIV/AIDS Reports, 2010, 7 (4) : 210 - 219
  • [35] Ambivalence and the biopolitics of HIV pre-exposure prophylaxis (PrEP) implementation
    Mark Gaspar
    Travis Salway
    Daniel Grace
    Social Theory & Health, 2022, 20 : 171 - 187
  • [36] Pre-exposure prophylaxis sorting among men who have sex with men
    Martinez, Joel E.
    Jonas, Kai J.
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2019, 31 (03): : 388 - 396
  • [37] Acceptability of Pre-Exposure Prophylaxis among Men Who Have Sex with Men and Transgender Women in Northern Thailand
    Yang, Daniel
    Chariyalertsak, Chonlisa
    Wongthanee, Antika
    Kawichai, Surinda
    Yotruean, Kriengkrai
    Saokhieo, Pongpun
    Guadamuz, Thomas
    Suwanvanichkij, Voravit
    Beyrer, Chris
    Chariyalertsak, Suwat
    PLOS ONE, 2013, 8 (10):
  • [38] Leveraging Social Media to Explore Black Women's Perspectives on HIV Pre-exposure Prophylaxis
    Hill, Bianca S.
    Patel, Viraj V.
    Haughton, Lorlette J.
    Blackstock, Oni J.
    JANAC-JOURNAL OF THE ASSOCIATION OF NURSES IN AIDS CARE, 2018, 29 (01): : 107 - 114
  • [39] Initial implementation of HIV pre-exposure prophylaxis for people who are incarcerated in Zambia: a cross-sectional observational study
    Lindsay, Brianna
    Nyirongo, Nasho
    Mwango, Linah
    Toeque, Mona Gekanju
    Masumba, Carol
    Litongola, James Paul
    Sikanyika, James
    Kabombo, Henry
    Moyo, Martin
    Siachibila, Steven
    Mudenda, James
    Tembo, Kalima
    Olowski, Pawel
    Olufunso, Adebayo
    Muchinda, Elizabeth
    Musonda, Bupe
    Okuku, Jackson
    Mwila, Annie
    Moonga, Clement N.
    Herce, Michael E.
    Claassen, Cassidy
    Claassen, Cassidy W.
    LANCET HIV, 2023, 10 (01): : E24 - E32
  • [40] Drug Resistance During HIV Pre-Exposure Prophylaxis
    Gibas, Kevin M.
    van den Berg, Polly
    Powell, Victoria E.
    Krakower, Douglas S.
    DRUGS, 2019, 79 (06) : 609 - 619